PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs

Pre-configured, scalable trial management system enables quicker study starts at a lower cost Calyx, the eClinical and eRegulatory solutions and services provider...
Continue Reading →
News

ACG Engineering launches the SMARTCOATER X•ONE Series

ACG's fastest tablet coater ensures optimised tablet coating ACG Engineering, a division of ACG, a leading supplier of integrated manufacturing solutions to the g...
Continue Reading →
News

Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib

The multinational Phase III study is evaluating a new pediatric granulated formulation of leniolisib in children aged 1 to 6 years with APDS, a rare primary immunode...
Continue Reading →
News

BHF and UKDRI announce first UK centre for vascular dementia research

The centre will help discover new treatments to prevent, halt and cure the condition. The British Heart Foundation (BHF) and the UK Dementia Research Institute (U...
Continue Reading →
News

LifeArc and UKDRI invest £14.5m into neurodegeneration research

The funding will be used to develop new diagnostic tests, treatments, and devices. LifeArc and the UK Dementia Research Institute (UKDRI) has invested £14.5m into...
Continue Reading →
News

European Commission Approves pharmaand GmbH’s Rubraca® (rucaparib) as a First-Line Maintenance Treatment in Advanced Ovarian Cancer

European Commission approval is based on the results from Phase 3 ATHENA- MONO trial and follows a positive opinion from the Committee for Medicinal Products for Hum...
Continue Reading →
News

JCVI advises UK government on gonorrhoea and mpox vaccinations

Both programmes will be offered to those most at risk of developing STIs. The Joint Committee on Vaccination and Immunisation (JCVI) has issued its advice to the ...
Continue Reading →
News

Study shows how congenital heart disease affects blood supply before birth

CHD is a common birth defect that affects the development of the heart and brain. Researchers from the School of Biomedical Engineering and Imaging Sciences and c...
Continue Reading →
News

Documentary highlights new targets to potentially treat motor neurone disease

The terminal condition currently affects around 5,000 people in the UK. A new documentary has highlighted the discovery of a promising new target for new treatmen...
Continue Reading →
News

IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial

The trial is evaluating an investigational cancer vaccine in combination with Keytruda. IO Biotech has announced that it has completed the enrolment of 380 patien...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026